Journal
PHARMACEUTICAL RESEARCH
Volume 19, Issue 11, Pages 1753-1756Publisher
KLUWER ACADEMIC/PLENUM PUBL
DOI: 10.1023/A:1020778001267
Keywords
pharmacokinetics; bevacizumab; monoclonal antibody; antigen-antibody clearance; VEGF